Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.

Autor: Ludwig J; B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Scally SW; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.; Department of Immunology, University of Toronto, Toronto, ON, Canada., Costa G; Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany., Hoffmann S; B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Murugan R; B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lossin J; B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Prieto K; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.; Department of Immunology, University of Toronto, Toronto, ON, Canada., Obraztsova A; B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lobeto N; B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Franke-Fayard B; Malaria Research Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Janse CJ; Malaria Research Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Lebas C; Vaccine Formulation Institute, Plan-les-Ouates, Switzerland., Collin N; Vaccine Formulation Institute, Plan-les-Ouates, Switzerland., Binter S; Kymab a Sanofi Company, Babraham Research Campus, Cambridge, UK., Kellam P; Kymab a Sanofi Company, Babraham Research Campus, Cambridge, UK.; Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, UK., Levashina EA; Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany. levashina@mpiib-berlin.mpg.de., Wardemann H; B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.wardemann@dkfz.de., Julien JP; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, ON, Canada. jean-philippe.julien@sickkids.ca.; Department of Immunology, University of Toronto, Toronto, ON, Canada. jean-philippe.julien@sickkids.ca.; Department of Biochemistry, University of Toronto, Toronto, ON, Canada. jean-philippe.julien@sickkids.ca.
Jazyk: angličtina
Zdroj: NPJ vaccines [NPJ Vaccines] 2023 Jun 05; Vol. 8 (1), pp. 86. Date of Electronic Publication: 2023 Jun 05.
DOI: 10.1038/s41541-023-00687-x
Databáze: MEDLINE